Supplement label guide
Schisandra: Human Evidence, Lignans, and Label Guide
Learn how to compare Schisandra species, fruit powder, extracts, lignan standardization, and blend disclosure without treating traditional use or a liver claim as proof of a clinical effect.
Also listed as: Schisandra chinensis, Schizandra, wu wei zi, wuweizi, five-flavor berry, or Chinese magnolia vine fruit. Schisandra sphenanthera is a different species, not a synonym.
Ingredient overview
Schisandra is a fruit preparation, not one interchangeable supplement format
Schisandra supplements are usually made from the dried fruit of Schisandra chinensis, a climbing plant used in East Asian herbal traditions. Wu wei zi is commonly translated as five-flavor fruit. That traditional name explains part of the ingredient’s history, but taste is not a reliable home test for identity, potency, or quality. 1
Modern products may contain whole-fruit powder, a concentrated extract, an extract standardized to total lignans or named schisandrins, or an undisclosed share of a multi-herb blend. Those formats can have different compositions, so the same number of milligrams does not make them equivalent.
Four formats that need different label questions
- Fruit or berry powder
- Ground botanical material. It usually provides no defined lignan concentration and should not be compared directly with an extract by milligrams alone.
- Fruit extract
- A concentrated preparation. An extract ratio may describe processing, but it does not replace a marker specification.
- Standardized extract
- An extract made to meet a declared marker level, such as a percentage of total lignans or schisandrins.
- Multi-herb blend
- Schisandra may be listed with Rhodiola, Eleuthero, or other herbs while its individual amount remains hidden.
Botanical identity
Schisandra chinensis and Schisandra sphenanthera are not the same species
Schisandra chinensis and Schisandra sphenanthera are both found in trade, but chemical profiling can distinguish them and their lignan patterns differ. Research performed with one species should not automatically be assigned to the other. 2 3
The common name alone leaves this distinction unresolved. A stronger label prints the full Latin species, fruit or berry as the material, the preparation type, and any declared marker in one place.
Identity becomes clearer when these fields appear together
- Full species
- Look for Schisandra chinensis or Schisandra sphenanthera, not only Schisandra.
- Plant material
- Fruit, berry, seed, and unspecified material are not equally informative descriptions.
- Preparation
- Powder, dry extract, liquid extract, and standardized extract describe different products.
- Research match
- A study matters most when its species, preparation, amount, and population resemble the product and claim being assessed.
Standardization markers
Lignan disclosure describes an extract more precisely than the word adaptogen
Schisandra fruit contains a group of compounds called lignans. Labels may declare total lignans, total schisandrins, or a named compound such as schisandrin. Spelling also varies, and schizandrin may appear on older or brand-specific labels.
A marker statement makes the disclosed potency easier to compare, but it does not prove that the finished product contains the stated amount. It also does not prove that one marker level is clinically superior for every intended use.
How to read a percentage declaration
- 500 mg extract at 9%
- The label implies 45 mg of the declared marker group per serving: 500 multiplied by 0.09.
- Total lignans
- A group specification. It is not necessarily the same as a percentage for one named lignan.
- Named schisandrin
- A more specific marker, but labels should make clear whether the number refers to one compound or a combined group.
- No marker disclosed
- The extract mass is still useful, but potency is harder to compare across products.
Human evidence
A few small trials do not establish one broad Schisandra effect
Human research is much narrower than the marketing. One randomized trial in 45 healthy postmenopausal women tested 1,000 mg per day of a specific S. chinensis extract for 12 weeks. The study reported a greater change in quadriceps strength and resting lactate than placebo, but it did not establish a universal energy, endurance, or anti-fatigue effect across Schisandra products. 4
Another small randomized trial enrolled 41 women with menopausal symptoms and analyzed 36 completers. A defined extract showed a difference in the study’s symptom score, with signals for hot flushes, sweating, and palpitations. That result is preliminary, population-specific evidence, not a general hormone-balancing claim. 5
Studies of combinations containing Schisandra cannot reveal how much of the result came from Schisandra itself. This includes adaptogen formulas that also contain Rhodiola, Eleuthero, holy basil, or other active ingredients. 6
Keep four study details attached to every claim
- Single ingredient or combination
- A blend result is not Schisandra-only evidence.
- Species and extract
- The tested botanical and preparation must match the label closely enough.
- Population and outcome
- Postmenopausal women, healthy adults, and clinical patients are different contexts.
- Scale and duration
- Small short trials are useful signals, not broad confirmation.
Claim review
Stress, liver, focus, and hangover claims require different evidence
Stress and calm energy
Adaptogen is a category and marketing term, not a measured outcome. Combination studies do not prove that Schisandra alone produces calm focus, smooths caffeine, or works immediately.
Liver support
Laboratory mechanisms and product-specific research should not be rewritten as a general detox claim. A supplement label cannot show faster toxin clearance or protection from liver injury.
Hangover relief
There is not a reliable human evidence base showing that a Schisandra supplement clears alcohol metabolites or prevents a hangover. That promise should not appear as established fact.
Sharper vision and reflexes
Traditional accounts and anecdotes are not substitutes for modern controlled evidence. A product should not be ranked by claims of sharper vision, faster reflexes, or crash-free energy.
Label reading
Read the species and preparation before ranking the milligrams
Check these details together
- Species
- A full Latin name is more informative than Schisandra or five-flavor berry alone.
- Fruit or seed
- Keep the disclosed plant material attached to the research and marker specification.
- Powder or extract
- Do not compare a whole-fruit powder and concentrated extract as if equal milligrams meant equal composition.
- Amount per serving
- Check the serving size as well as the number printed beside the ingredient.
- Marker declaration
- Note whether the label names total lignans, schisandrins, or another specific marker and whether it gives a percentage or amount.
- Blend transparency
- A total blend weight does not disclose the amount of Schisandra inside it.
- Other active ingredients
- Rhodiola, Eleuthero, caffeine, liver-support botanicals, and medications all change the surrounding context.
Label comparison
Four Schisandra labels can describe four different products
Four illustrative disclosure patterns
- Label A
- Schisandra chinensis fruit powder, 1,000 mg. Species, material, form, and amount are clear. Lignan potency is not standardized.
- Label B
- Schisandra chinensis fruit extract, 500 mg, standardized to 9% schisandrins. The label implies 45 mg of the declared marker group per serving.
- Label C
- Schisandra extract, 500 mg. Amount and extract wording are shown, but species, material, and marker specification are incomplete.
- Label D
- Adaptogen blend, 600 mg: Rhodiola, Schisandra, Eleuthero. The total blend mass is disclosed, but each ingredient’s individual amount is hidden.
The most transparent label is not automatically the most effective product
Better disclosure makes comparison more defensible. It does not prove botanical identity, actual marker content, absorption, clinical benefit, medication compatibility, or personal suitability.
Dose context
There is no universal Schisandra dose across powders and extracts
Human studies have used specific preparations rather than one interchangeable Schisandra dose. The 12-week strength study used 1,000 mg per day of its tested extract, while commercial labels may show a different extract, a marker percentage, or whole-fruit powder. One study amount is not a target for every product or goal. 4
Health Canada’s 2024 assessment of Schisandra fruit extract in supplemented foods found insufficient information to establish acceptable conditions above 200 mg per day of dried-berry crude equivalent. That decision applies to a specific Canadian food regulatory context. It is not a universal supplement dose, efficacy threshold, or upper limit for every extract. 7
Why the numbers cannot be placed on one simple ladder
- Powder milligrams
- Describe the mass of ground botanical material.
- Extract milligrams
- Describe a concentrated preparation whose composition depends on processing.
- Marker percentage
- Adds potency context but does not establish an outcome-specific effective dose.
- Crude equivalent
- Describes source-material equivalence and is not the same as extract mass or lignan amount.
Safety and interactions
Medication interaction evidence matters more than the harmless-berry image
In a study of 12 healthy men, 300 mg of a Schisandra chinensis extract twice daily for 14 days increased exposure to talinolol, a transporter-sensitive medicine. This is direct human evidence that at least one Schisandra preparation can alter drug handling. 8
A separate study in 12 healthy men found that a Schisandra sphenanthera extract substantially increased tacrolimus exposure. The species and product were specific, so this result should not be converted into a claim that every Schisandra product interacts with every medicine. It does justify particular caution with tacrolimus and other medicines where small concentration changes can be clinically important. 9
Health Canada also identified drug-metabolizing enzymes, talinolol, warfarin, blood-thinning medicines, and reproductive safety as areas needing more information for higher-exposure supplemented-food use. That is a data-gap warning, not proof of a specific interaction with every named medicine. 7
Contexts that need clinician or pharmacist review
- Tacrolimus
- A human pharmacokinetic study found a substantial increase in tacrolimus exposure with a specific Schisandra sphenanthera extract. Do not add Schisandra during tacrolimus treatment without the prescriber’s involvement and appropriate monitoring. 9
- Narrow-therapeutic-index medicines
- Small exposure changes can be clinically important, so a generic interaction checker is not enough.
- Blood-thinning medicines
- Product-specific evidence is incomplete. Review the exact medicine and extract rather than assuming compatibility.
- Pregnancy or breastfeeding
- Reproductive and developmental safety information is not sufficient for routine supplemental use.
Label versus laboratory
A detailed label is not proof of identity, potency, purity, or clinical benefit
A label can disclose species, fruit or seed, powder or extract, amount per serving, a lignan percentage, and blend composition. It cannot by itself verify botanical identity, actual lignan content, purity, contaminants, solvent residues, adulteration, stability, or batch quality.
It also cannot determine whether the product will improve stress, energy, liver function, menopause symptoms, or exercise outcomes for an individual. Those are separate evidence and personal-health questions.
NutriDetector approach
How NutriDetector reads Schisandra labels
NutriDetector reviews the disclosed Schisandra species, fruit preparation, amount per serving, extract form, lignan or schisandrin standardization, and blend transparency. When the species or individual amount is not disclosed, that uncertainty remains visible rather than being treated as known.
When products are added to My Stack, NutriDetector can compare disclosed Schisandra amounts, forms, standardization, and formula context across supplements. It does not treat fruit powder, extract weight, lignan percentages, crude equivalents, or a shared blend total as interchangeable quantities.
NutriDetector evaluates what the label declares. It cannot authenticate the botanical species, verify lignan content or contaminants, predict a clinical effect, clear medication interactions, or determine personal suitability.
Analyze the full formula
Check the species behind the adaptogen claim.
NutriDetector can compare disclosed Schisandra forms, amounts, standardization, and blend transparency across products added to My Stack. It cannot verify botanical identity, predict benefit, clear medication interactions, or determine personal suitability.
Questions and boundaries
Schisandra supplement FAQ
What is Schisandra?
Schisandra is a botanical supplement usually made from the fruit of Schisandra chinensis. Products may contain whole-fruit powder, an extract, a standardized extract, or Schisandra inside a multi-herb blend.
Is Schisandra the same as Schisandra chinensis?
Schisandra is a common name that may be used loosely. Schisandra chinensis is a specific species. A stronger label prints the full Latin species instead of leaving the botanical identity at the common-name level.
Are Schisandra chinensis and Schisandra sphenanthera interchangeable?
No. They are different species with different chemical profiles. Evidence or interaction data from one species should not automatically be assigned to the other.
What are lignans and schisandrins on a Schisandra label?
Lignans are a group of compounds found in Schisandra. A label may declare total lignans, total schisandrins, or a named compound such as schisandrin. The exact wording matters because a group percentage is not the same as an amount for one named compound.
Is a standardized Schisandra extract always better?
Not automatically. Standardization makes the declared potency easier to compare, but it does not prove identity, purity, clinical effectiveness, or personal suitability. The marker also needs to match the evidence behind the intended claim.
What is a typical Schisandra dose?
There is no universal dose that applies across fruit powders, different extracts, marker percentages, and intended uses. Keep the species, preparation, serving size, standardization, and study context attached to any number.
Does Schisandra reduce stress or improve energy?
Human evidence is limited and product-specific. Small single-ingredient studies and multi-herb trials cannot establish one reliable stress or energy effect across all Schisandra supplements.
Does Schisandra detox the liver or prevent hangovers?
Reliable human evidence does not establish that a general Schisandra supplement speeds alcohol-metabolite clearance, prevents hangovers, or detoxifies the liver. Laboratory mechanisms and traditional use should not be presented as proof of those outcomes.
Can Schisandra interact with medications?
Yes, some specific Schisandra extracts have changed drug exposure in human studies. The clearest caution involves tacrolimus and other medicines where concentration changes can matter. Ask a clinician or pharmacist to review the exact product and medication.
Can I take Schisandra during pregnancy or breastfeeding?
Safety of concentrated Schisandra supplements during pregnancy and breastfeeding has not been established. Reproductive and developmental safety data are limited, so use should be reviewed with a qualified clinician rather than inferred from traditional use or food exposure.
How does NutriDetector evaluate Schisandra?
NutriDetector can review disclosed Schisandra species, forms, amounts, serving context, standardization, and blend transparency and compare products added to My Stack. It cannot authenticate botanical material, verify lignan content or contaminants, predict benefit, clear medicines, or determine whether a product is safe or suitable for a person.
Scientific references and regulatory sources
- World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3: Fructus Schisandrae. WHO monograph
- Guo LY, Hung TM, Bae KH, et al. Differentiation of Schisandra chinensis and Schisandra sphenanthera using metabolite profiles based on UPLC-MS and GC-MS. J Pharm Biomed Anal. 2011;56(3):577-586. PubMed
- Lu Y, Chen DF. Analysis of Schisandra chinensis and Schisandra sphenanthera. J Chromatogr A. 2009;1216(11):1980-1990. PubMed
- Park J, Han S, Park H. Effect of Schisandra Chinensis Extract Supplementation on Quadriceps Muscle Strength and Fatigue in Adult Women: A Randomized, Double-Blind, Placebo-Controlled Trial. Int J Environ Res Public Health. 2020;17(7):2475. PubMed
- Park JY, Kim KH. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Climacteric. 2016;19(6):574-580. PubMed
- Aslanyan G, Amroyan E, Gabrielyan E, Nylander M, Wikman G, Panossian A. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine. 2010;17(7):494-499. PubMed
- Health Canada. Decision on Schisandra chinensis fruit extract as a supplemental ingredient in foods. 2024. Health Canada
- Fan L, Mao XQ, Tao GY, et al. Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica. 2009;39(3):249-254. PubMed
- Xin HW, Wu XC, Li Q, et al. Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers. Br J Clin Pharmacol. 2007;64(4):469-475. PubMed
